Dr. Reddy’s Launches Allegra Generic

Law360, New York (April 17, 2006, 12:00 AM EDT) -- India's Dr. Reddy's Laboratories has said it will begin marketing a generic version of the blockbuster allergy drug Allegra in the United States, disregarding a pending patent infringement lawsuit brought by the drug’s developer, Sanofi-Aventis SA.

Although rival generic drug makers Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. began marketing their versions in 2005, demand for the drug appears high enough for an at-risk launch, with Allegra generating about $1 billion in revenue last year.

Dr. Reddy's said it would immediately start marketing fexofenadine, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.